Abstract
There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.
| Original language | English |
|---|---|
| Article number | ofac374 |
| Journal | Open Forum Infectious Diseases |
| Volume | 9 |
| Issue number | 8 |
| DOIs | |
| State | Published - 1 Aug 2022 |
| Externally published | Yes |
Keywords
- COVID-19
- extracorporeal membrane oxygenation
- fungemia